Human Papillomavirus Vaccine Updates
A new HPV vaccine is available for females, and the original HPV vaccine is now licensed for males.
By Robin Drucker, MD
June 23, 2010
Covering:
Centers for Disease Control (CDC)., MMWR Morb Mortal Wkly Rep 2010 May 28; 59:626
Centers for Disease Control (CDC)., MMWR Morb Mortal Wkly Rep 2010 May 28; 59:630
Young Women Have Few Sequelae from Early Puberty
Psychiatry Summary and Comment
But teenage promiscuity in early maturers raises the risk for sexually transmitted diseases and hepatitis.
By Barbara Geller, MD
June 21, 2010
Covering:
Copeland W et al., Am J Psychiatry 2010 May 17
For Stress Incontinence, Which Midurethral Sling Is Better?
Women's Health Summary and Comment
Efficacy of retropubic and transobturator approaches were equivalent, but adverse event profiles differed.
Missed Opportunities: Testing for BRCA1 and BRCA2 Mutations in Ovarian Cancer Patients
Women's Health Summary and Comment
Only half of ovarian cancer patients at substantial risk for <$EMPH_O>BRCA<$EMPH_C> mutations were referred for genetic counseling.
By Ann J. Davis, MD
June 10, 2010
Covering:
Meyer LA et al., Obstet Gynecol 2010 May; 115:945
Can a Multimarker Assay Improve Screening for Ovarian Cancer?
Women's Health Summary and Comment
Free
A four-marker panel performed substantially better than CA 125 alone.
By Andrew M. Kaunitz, MD
May 20, 2010
Covering:
Yurkovetsky Z et al., J Clin Oncol 2010 May 1; 28:2159
Hensley ML., J Clin Oncol 2010 May 1; 28:2128
U.S. Congenital Syphilis Rates on the Rise
Women's Health Summary and Comment
Following a 14-year decline, congenital syphilis rates rose from 2003 through 2008.
By Diane E. Judge, APN/CNP
May 20, 2010
Covering:
Centers for Disease Control and Prevention (CDC)., MMWR Morb Mortal Wkly Rep 2010 Apr 16; 59:413
Trichomonas vaginalis Among Teens
Women's Health Summary and Comment
In a cohort of high-risk teens, incidence of <$EMPH_O>T. vaginalis<$EMPH_C> was 22 cases per 100 person-years.
By Anna Wald, MD, MPH
May 20, 2010
Covering:
Krashin JW et al., Sex Transm Dis 2010 Mar 26
Can Oral Contraceptives Prevent Endometrioma Recurrence After Surgical Excision?
Women's Health Summary and Comment
Endometriomas were less likely to recur, and, if they did, were smaller in women who used oral contraceptives.
By Robert W. Rebar, MD
May 20, 2010
Covering:
Seracchioli R et al., Fertil Steril 2010 Jan; 93:52
Tampon Users More Likely to Choose Vaginal Ring over Oral Contraceptive Pills
Women's Health Summary and Comment
Women who used tampons were slightly more likely than nonusers to choose the vaginal ring over OCPs.
Home-Based Screening for Sexually Transmitted Infections
Women's Health Summary and Comment
Patients vastly preferred collection of vaginal specimens at home over clinic-based collection.
Rectal Testing for Chlamydial and Gonorrheal Infections
Women's Health Summary and Comment
At one large clinic, rectal testing increased the overall detection rate of chlamydial and gonorrheal infections by 15%.
Can Chlamydia Screening Prevent Pelvic Inflammatory Disease?
Women's Health Summary and Comment
We still don't know: Most cases of PID occurred in women who tested negative at baseline.
By Ann J. Davis, MD
April 29, 2010
Covering:
Oakeshott P et al., BMJ 2010 Apr 8; 340:c1642
Does Cervical Priming Ease Consecutive Insertion of the Levonorgestrel-Releasing Intrauterine System?
Women's Health Summary and Comment
Misoprostol did not affect ease of insertion or pain in women with previous successful LNG-IUS insertions.
By Ann J. Davis, MD
April 29, 2010
Covering:
Heikinheimo O et al., Contraception 2010 Mar 1
Differentiated VIN to Squamous Cell Carcinoma: p53 Role
Dermatology Summary and Comment
The p53 protein appears to have a role in the evolution of vulvar squamous cell carcinoma.
By Angelica Selim, MD
April 23, 2010
Covering:
Pinto AP et al., Mod Pathol 2010 Mar; 23:404
Determining Which Adnexal Masses Are Likely to Be Malignant
Women's Health Summary and Comment
Vaginal ultrasound combined with CA 125 evaluation has good combined prognostic value.
By Andrew M. Kaunitz, MD
April 22, 2010
Covering:
McDonald JM et al., Obstet Gynecol 2010 Apr; 115:687
Falcone T., Obstet Gynecol 2010 Apr; 115:680
North American Menopause Society's 2010 Position Statement on Postmenopausal Hormone Use
Women's Health Summary and Comment
Free
New evidence as well as recent analyses of benefit-risk ratios shape revisions.
By Diane E. Judge, APN/CNP
April 15, 2010
Covering:
North American Menopause Society., Menopause 2010 Mar/Apr; 17:242
New Medical Approach to Shrinking Uterine Fibroids?
Women's Health Summary and Comment
Aromatase inhibitor therapy reduced fibroid size in reproductive-aged women.
Intrauterine Contraception in Adolescents
Women's Health Summary and Comment
Pilot study suggests that this safe contraceptive method is acceptable to teens.
By Ann J. Davis, MD
April 15, 2010
Covering:
Godfrey EM et al., Contraception 2010 Feb; 81:123
Is Do-It-Yourself Home Cervicovaginal Sampling an Effective Screening Strategy?
Women's Health Summary and Comment
Self-sampling response rates and yield of high-grade cervical lesions in women who tested positive for human papillomavirus were high.
Urinary and Anal Incontinence Are Common During and After Pregnancy
Women's Health Summary and Comment
Older age, greater weight gain, and vaginal delivery were risk factors for both forms of incontinence.
By Wendy S. Biggs, MD
April 15, 2010
Covering:
Solans-Domènech M et al., Obstet Gynecol 2010 Mar; 115:618
Bones Can Bounce Back
Bone-density loss in adolescents who use depot medroxyprogesterone acetate for contraception is reversible.
Is Risk for Venous Thromboembolism Affected by Route and Type of Menopausal Hormone Therapy?
Women's Health Summary and Comment
Free
Results of a large observational study suggest that transdermal (in contrast with oral) estrogens do not raise risk.
By Robert W. Rebar, MD
April 8, 2010
Covering:
Canonico M et al., Arterioscler Thromb Vasc Biol 2010 Feb; 30:340
Cushman M., Arterioscler Thromb Vasc Biol 2010 Feb; 30:136
Untangling the Relations Between Hormone Therapy and Coronary Heart Disease
Women's Health Summary and Comment
Analysis showed no evidence of excess CHD risk during the first 2 years of combined hormone therapy initiated within 10 years of menopause; cardioprotection might develop after 6 years.
In the Long Run, Oral Contraceptive Pills Don't Raise Mortality
Women's Health Summary and Comment
On the contrary, pill use conveyed a modest mortality benefit.
By Wendy S. Biggs, MD
April 8, 2010
Covering:
Hannaford PC et al., BMJ 2010 Mar 11; 340:c927
Strategies for Managing Stress Incontinence Are Not Additive or Long-Lasting
Women's Health Summary and Comment
Behavioral therapy worked better than pessary at 3 months, but the difference did not persist at 12 months.
By Wendy S. Biggs, MD
March 25, 2010
Covering:
Richter HE et al., Obstet Gynecol 2010 Mar; 115:609
